The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
暂无分享,去创建一个
Elissa Murphy | S. Johnston | D. Schwartz | M. Moffatt | A. Russell | A. Wells | Elissa Murphy | T. Maher | M. Cox | W. Cookson | P. Mallia | David A Schwartz | Saffron A G Willis-Owen | Phillip L Molyneaux | Michael J Cox | Patrick Mallia | Kirsty E Russell | Anne-Marie Russell | Sebastian L Johnston | Athol U Wells | William O C Cookson | Toby M Maher | Miriam F Moffatt | S. Willis-Owen | K. Russell | P. Molyneaux
[1] Mihai Pop,et al. Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples , 2009, PLoS Comput. Biol..
[2] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[3] N. Ahmed,et al. Improved Detection of Bifidobacteria with Optimised 16S rRNA-Gene Based Pyrosequencing , 2012, PloS one.
[4] A. Nicholson,et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis , 2013, Thorax.
[5] T. Maher,et al. Respiratory microbiome in IPF: cause, effect, or biomarker? , 2014, The Lancet. Respiratory medicine.
[6] J. Gauldie,et al. Let It Be: microRNAs impact interstitial lung disease. , 2011, American journal of respiratory and critical care medicine.
[7] D. Coultas,et al. Is idiopathic pulmonary fibrosis an environmental disease? , 2006, Proceedings of the American Thoracic Society.
[8] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[9] Hongzhe Li,et al. Disordered Microbial Communities in the Upper Respiratory Tract of Cigarette Smokers , 2010, PloS one.
[10] Emily S. Charlson,et al. Assessing Bacterial Populations in the Lung by Replicate Analysis of Samples from the Upper and Lower Respiratory Tracts , 2012, PloS one.
[11] Lior Pachter,et al. Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.
[12] Meilan K. Han,et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. , 2014, The Lancet. Respiratory medicine.
[13] Brent S. Pedersen,et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.
[14] E. Chilvers,et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial , 2012, Thorax.
[15] 马建新,et al. 用FEV6.0代替FVC诊断气道阻塞和肺功能受限[英]/Swanney MP…∥Am J Respir Crit Care Med. , 2002 .
[16] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[17] K. D. Zylan,et al. Article , 1996, Physiology & Behavior.
[18] Charlie Strange,et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. , 2012, American journal of respiratory and critical care medicine.
[19] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[20] Kevin J Anstrom,et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.
[21] S. Johnston,et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[22] J. Loyd,et al. Genetics in Pulmonary Fibrosis—Familial Cases Provide Clues to the Pathogenesis of Idiopathic Pulmonary Fibrosis , 2011, The American journal of the medical sciences.
[23] J. Derisi,et al. At a Glance Commentary , 2022 .
[24] Sang Joon Kim,et al. A Mathematical Theory of Communication , 2006 .
[25] Naftali Kaminski,et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.
[26] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[27] C. Quince,et al. Accurate determination of microbial diversity from 454 pyrosequencing data , 2009, Nature Methods.
[28] Claude E. Shannon,et al. The mathematical theory of communication , 1950 .
[29] Rob Knight,et al. PyNAST: a flexible tool for aligning sequences to a template alignment , 2009, Bioinform..
[30] R. Hubbard,et al. The rising incidence of idiopathic pulmonary fibrosis in the UK , 2011, Thorax.
[31] G. Laurent,et al. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? , 2007, European Respiratory Journal.
[32] Robert C. Edgar,et al. BIOINFORMATICS APPLICATIONS NOTE , 2001 .
[33] Ivana V. Yang,et al. Muc5b is required for airway defence , 2013, Nature.
[34] B. Haas,et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. , 2011, Genome research.
[35] T. Maher,et al. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis , 2013, European Respiratory Review.
[36] Jong-Min Song,et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.
[37] Rob Knight,et al. UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context , 2006, BMC Bioinformatics.
[38] I. Noth,et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. , 2013, JAMA.
[39] Joel Cooper,et al. The lung tissue microbiome in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[40] Ivana V. Yang,et al. The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis , 2012, PloS one.
[41] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[42] H. Collard,et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[43] M. Moffatt,et al. Upper Airways Microbiota in Antibiotic-Naïve Wheezing and Healthy Infants from the Tropics of Rural Ecuador , 2012, PloS one.
[44] Eoin L. Brodie,et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. , 2010, Omics : a journal of integrative biology.